D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 16 370 KRW -4.88% Market Closed
Market Cap: 719.7B KRW
Have any thoughts about
Dongkook Pharmaceutical Co Ltd?
Write Note

Relative Value

The Relative Value of one Dongkook Pharmaceutical Co Ltd stock under the Base Case scenario is 26 640.47 KRW. Compared to the current market price of 16 370 KRW, Dongkook Pharmaceutical Co Ltd is Undervalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
26 640.47 KRW
Undervaluation 39%
Relative Value
Price
D
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
74
vs Industry
69
Median 3Y
1.1
Median 5Y
1.3
Industry
2.6
Forward
0.9
vs History
57
vs Industry
29
Median 3Y
14.6
Median 5Y
14.9
Industry
23
Forward
10.9
vs History
42
vs Industry
23
Median 3Y
17.4
Median 5Y
17.5
Industry
17.8
vs History
9
vs Industry
3
Median 3Y
56.3
Median 5Y
56.3
Industry
25.4
vs History
73
vs Industry
50
Median 3Y
1.4
Median 5Y
1.8
Industry
2.2
vs History
74
vs Industry
71
Median 3Y
1
Median 5Y
1.2
Industry
2.8
Forward
0.9
vs History
66
vs Industry
72
Median 3Y
1.8
Median 5Y
2.1
Industry
5.4
vs History
63
vs Industry
37
Median 3Y
7.8
Median 5Y
8.2
Industry
13.7
Forward
6.5
vs History
57
vs Industry
35
Median 3Y
10.4
Median 5Y
10.5
Industry
17.2
Forward
8.6
vs History
36
vs Industry
24
Median 3Y
16.4
Median 5Y
16.4
Industry
16.5
vs History
19
vs Industry
3
Median 3Y
80.4
Median 5Y
51.9
Industry
19.3
vs History
68
vs Industry
54
Median 3Y
1.1
Median 5Y
1.4
Industry
2

Multiples Across Competitors

Competitors Multiples
Dongkook Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
719.8B KRW 0.9 13.2 7 9.3
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.5B USD 18.5 90.4 48.6 54.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
364.1B USD 4.2 24.8 12 15.6
US
Merck & Co Inc
NYSE:MRK
248.4B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.5B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.5 169.4 253.8
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7

See Also

Discover More
Back to Top